hroughout the global push to produce COVID-19 vaccines, pharma companies have frequently come under fire for unequal access to their shots. Oxfam, in a bid to force b...

Last last year, Moderna lost a legal bid to invalidate two Arbutus Biopharma patents tied to the delivery of its COVID-19 vaccine. At the time, it wasn’t so much a qu...

Three lawmakers have thrown their support behind a plan that could empower the National Institutes of Health (NIH) to supply cheaper versions of Pfizer and Astellas' ...

While AstraZeneca’s 2021 COVID-19 shot sales paled in comparison to Pfizer and Moderna’s vaccine revenues, the British drugmaker remained a pandemic force—and its CEO...

With the FDA set for a speedy review of Novartis’ new targeted radioligand therapy for a stubborn form of prostate cancer, a new survey by Cardinal Health shows the d...

CEO, check. Chairman, check. Now, a new name for GlaxoSmithKline's consumer health unit? Also check. Haleon, pronounced “Hay-Lee-On,” will be GSK Consumer Health’s ne...

Argenx nabbed an FDA approval for its rare disease drug Vyvgart just before Christmas and is wasting no time launching the generalized myasthenia gravis (gMG) med and...

In her 2019 Netflix standup special “Not Normal,” comedian Wanda Sykes jokes that if men got hot flashes, “they would blow the sun up.” “There’s no way in the world ...

Moderna’s COVID-19 vaccine production partner Recipharm unveiled not one, but two acquisitions on Friday amid an expansion sprint that’s been ongoing since last summe...

Animal health giant Elanco completed the sale of a pair of manufacturing facilities to TriRx Pharmaceutical Services, a Connecticut-based CDMO. Financial terms of th...